Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1946]
News [3593]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
FDA approves ado-trastuzumab emtansine for early breast cancer
FDA approves ado-trastuzumab emtansine for early breast cancer
Vaccine design can dramatically improve cancer immunotherapies
Vaccine design can dramatically improve cancer immunotherapies
Biomarker may predict if immunotherapy is right choice for colorectal cancer patients
Biomarker may predict if immunotherapy is right choice for colorectal cancer patients
Mutational intensity influences a tumour's response to PD-1 immunotherapy
Mutational intensity influences a tumour's response to PD-1 immunotherapy
Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy
Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy
Phase 1 interim results for anti-BCMA CAR T-cell therapy in relapse refractory multiple myeloma
Phase 1 interim results for anti-BCMA CAR T-cell therapy in relapse refractory multiple myeloma
Synthetic biology used to target cancer cells while sparing healthy tissue, study reports
Synthetic biology used to target cancer cells while sparing healthy tissue, study reports
Researchers ready B cells for novel cell therapy
Researchers ready B cells for novel cell therapy
Last Month in Oncology with Dr. Bishal Gyawali: April 2019
Last Month in Oncology with Dr. Bishal Gyawali: April 2019
Researchers find new target to improve response to cancer immunotherapy
Researchers find new target to improve response to cancer immunotherapy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation